Use of GLP-1 receptor ... effects on the optic nerve and microvascular changes in the retinal blood supply," they wrote. The study doesn't explore the pros and cons of GLP-1 drugs such as side ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

The study findings suggest a possible link between semaglutide use and an increased risk of NAION in patients with diabetes.

The firm is urging individuals who have suffered serious eye injuries after taking these widely prescribed GLP-1 receptor agonist ... off blood flow to the optic nerve. Patients who took these ...

Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with type 2 diabetes is linked to a reduced risk of developing certain hematologic cancers compared to insulin and metformin.